Skip to main content
Top
Published in: International Urology and Nephrology 5/2013

01-10-2013 | Nephrology - Original Paper

Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus

Authors: Yit-Sheung Yap, Hung-Yi Chuang, Wen-Che Chi, Cheng-Hao Lin, Yi-Wen Wu, Pai-Chun Chang, Yi-Chun Liu

Published in: International Urology and Nephrology | Issue 5/2013

Login to get access

Abstract

Purpose

Diabetic nephropathy and proteinuria are important risk factors for both end-stage renal disease and cardiovascular events. The present study aimed to identify the factors associated with nephrotic-range proteinuria in patients with advanced diabetic nephropathy.

Methods

This cross-sectional study enrolled 386 diabetic patients with chronic kidney disease (CKD) stages 3–5, from our outpatient Department of Nephrology. Urinary protein-to-creatinine ratio was recorded. Additionally, other laboratory parameters, body mass index, blood pressure, comorbidities, and medications were also reviewed.

Results

The mean age of the patients was 65.1 ± 11.6 years. Among patients with CKD stage 3 and 4, the odds ratio (OR) for nephrotic-range proteinuria in relation with systolic blood pressure significantly increased starting from 121 mmHg (OR 7.04 and 11.79 for systolic blood pressure of 121–140 and ≥141 mmHg, respectively, in comparison with systolic blood pressure below 121 mmHg). In addition, serum phosphorus ≥4.7 mg/dl was associated with significantly higher risk (OR 15.45) for severe proteinuria, compared with a phosphorus level ≤2.6 mg/dl. Finally, hypertriglyceridemia ≥241 mg/dl was also associated with higher OR for severe proteinuria, compared with a triglyceride level ≤200 mg/dl. Similar associations were found in patients with CKD stage 5.

Conclusions

Higher systolic blood pressure, serum phosphorus, and triglyceride levels are associated with nephrotic-range proteinuria in patients with diabetic nephropathy and CKD stage 3–5. Further studies should clarify whether a reduction in serum phosphorus would lead to a decrease in proteinuria in these patients.
Literature
1.
go back to reference American Diabetes Association (2003) Standards of medical care for patients with diabetes mellitus. Diabetes Care 26:33–50CrossRef American Diabetes Association (2003) Standards of medical care for patients with diabetes mellitus. Diabetes Care 26:33–50CrossRef
2.
go back to reference Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869PubMedCrossRef Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869PubMedCrossRef
3.
go back to reference Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D (2000) Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med 109:1–8PubMedCrossRef Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D (2000) Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med 109:1–8PubMedCrossRef
4.
go back to reference Taal MW, Brenner BM (2006) Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int 70:1694–1705PubMedCrossRef Taal MW, Brenner BM (2006) Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int 70:1694–1705PubMedCrossRef
5.
go back to reference Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM (2005) The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 46:863–870PubMedCrossRef Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM (2005) The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 46:863–870PubMedCrossRef
7.
go back to reference Ramirez SP, McClellan W, Port FK, Hsu SI (2002) Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol 13(7):1907–1917PubMedCrossRef Ramirez SP, McClellan W, Port FK, Hsu SI (2002) Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol 13(7):1907–1917PubMedCrossRef
8.
go back to reference Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, UKPDS Study Group (2006) Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes Care 55:1832–1839CrossRef Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, UKPDS Study Group (2006) Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes Care 55:1832–1839CrossRef
9.
go back to reference Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Japan Diabetes Clinical Data Management Study Group (2009) Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 24:1212–1219. doi:10.1093/ndt/gfn603 PubMedCrossRef Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Japan Diabetes Clinical Data Management Study Group (2009) Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 24:1212–1219. doi:10.​1093/​ndt/​gfn603 PubMedCrossRef
10.
go back to reference Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, Wang W, Zuo Y, Gu H, Xiang K (2009) Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant 24:3724–3731. doi:10.1093/ndt/gfp349 PubMedCrossRef Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, Wang W, Zuo Y, Gu H, Xiang K (2009) Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant 24:3724–3731. doi:10.​1093/​ndt/​gfp349 PubMedCrossRef
11.
go back to reference Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R (2010) Chronic kidney disease in hypertension under specialist care the I-DEMAND study. J Hypertens 28:156–162PubMedCrossRef Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R (2010) Chronic kidney disease in hypertension under specialist care the I-DEMAND study. J Hypertens 28:156–162PubMedCrossRef
12.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef
13.
go back to reference Foundation NK (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:1–266 Foundation NK (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:1–266
14.
go back to reference Foundation NK (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:1–201 Foundation NK (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:1–201
15.
go back to reference Yuyun MF, Adler AI, Wareham NJ (2005) What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens 14:271–276PubMedCrossRef Yuyun MF, Adler AI, Wareham NJ (2005) What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens 14:271–276PubMedCrossRef
16.
go back to reference Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44:54–64CrossRef Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44:54–64CrossRef
17.
go back to reference Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157:1413–1418PubMedCrossRef Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157:1413–1418PubMedCrossRef
18.
go back to reference Sexton DJ, Kinsella SM, Eustace JA (2012) Serum phosphate varies with degree of proteinuria in nephrotic syndrome and is associated with elevated pulse wave velocity. J Nephrol. doi:10.5301/jn.5000186 PubMed Sexton DJ, Kinsella SM, Eustace JA (2012) Serum phosphate varies with degree of proteinuria in nephrotic syndrome and is associated with elevated pulse wave velocity. J Nephrol. doi:10.​5301/​jn.​5000186 PubMed
19.
go back to reference Yap YS, Chi WC, Lin CH, Wu YW, Liu YC (2012) Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study. Int Urol Nephrol. doi:10.1007/s11255-11012-10163-11257 PubMed Yap YS, Chi WC, Lin CH, Wu YW, Liu YC (2012) Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study. Int Urol Nephrol. doi:10.​1007/​s11255-11012-10163-11257 PubMed
20.
go back to reference Pijls LT, de Vries H, Donker AJ, van Eijk JT (1999) The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Nephrol Dial Transplant 14:1445–1453PubMedCrossRef Pijls LT, de Vries H, Donker AJ, van Eijk JT (1999) The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Nephrol Dial Transplant 14:1445–1453PubMedCrossRef
21.
go back to reference Kojima F, Uchida K, Ogawa T, Tanaka Y, Nitta K (2008) Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Int Urol Nephrol 40:1067–1074PubMedCrossRef Kojima F, Uchida K, Ogawa T, Tanaka Y, Nitta K (2008) Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Int Urol Nephrol 40:1067–1074PubMedCrossRef
22.
go back to reference Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, Jorgetti V, Moysés RM (2011) FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 6:241–247PubMedCrossRef Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, Jorgetti V, Moysés RM (2011) FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 6:241–247PubMedCrossRef
23.
go back to reference Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C (2010) FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78:679–685PubMedCrossRef Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C (2010) FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78:679–685PubMedCrossRef
24.
go back to reference Ix JH, Shlipak MG, Wassel CL, Whooley MA (2010) Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant 25:993–997PubMedCrossRef Ix JH, Shlipak MG, Wassel CL, Whooley MA (2010) Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant 25:993–997PubMedCrossRef
25.
go back to reference Dhingra R, Sullivan LM, Fox CS, Wang TJ, D’Agostino RB Sr, Gaziano JM, Vasan RS (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879–885PubMedCrossRef Dhingra R, Sullivan LM, Fox CS, Wang TJ, D’Agostino RB Sr, Gaziano JM, Vasan RS (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879–885PubMedCrossRef
26.
go back to reference Taskapan H (2012) Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels? Int Urol Nephrol 44:1135–1144PubMedCrossRef Taskapan H (2012) Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels? Int Urol Nephrol 44:1135–1144PubMedCrossRef
27.
go back to reference Sekiguchi S, Suzuki A, Asano S, Nishiwaki-Yasuda K, Shibata M, Nagao S, Yamamoto N, Matsuyama M, Sato Y, Yan K, Yaoita E, Itoh M (2011) Phosphate overload induces podocyte injury via type III Na-dependent phosphate transporter. Am J Physiol Renal Physiol 300:848–856CrossRef Sekiguchi S, Suzuki A, Asano S, Nishiwaki-Yasuda K, Shibata M, Nagao S, Yamamoto N, Matsuyama M, Sato Y, Yan K, Yaoita E, Itoh M (2011) Phosphate overload induces podocyte injury via type III Na-dependent phosphate transporter. Am J Physiol Renal Physiol 300:848–856CrossRef
28.
go back to reference Fox ER, Benjamin EJ, Sarpong DF, Nagarajarao H, Taylor JK, Steffes MW, Salahudeen AK, Flessner MF, Akylbekova EL, Fox CS, Garrison RJ, Taylor HA Jr (2010) The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol 11:1. doi:10.1186/1471-2369-11-1 PubMedCrossRef Fox ER, Benjamin EJ, Sarpong DF, Nagarajarao H, Taylor JK, Steffes MW, Salahudeen AK, Flessner MF, Akylbekova EL, Fox CS, Garrison RJ, Taylor HA Jr (2010) The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol 11:1. doi:10.​1186/​1471-2369-11-1 PubMedCrossRef
29.
go back to reference Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, Boeschoten EW, Huisman RM, Krediet RT, Dekker FW, PREPARE Study Group (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22:2909–2916. doi:10.1093/ndt/gfm286 PubMedCrossRef Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, Boeschoten EW, Huisman RM, Krediet RT, Dekker FW, PREPARE Study Group (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22:2909–2916. doi:10.​1093/​ndt/​gfm286 PubMedCrossRef
30.
go back to reference Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A (2011) Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 21:295–302PubMedCrossRef Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A (2011) Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 21:295–302PubMedCrossRef
31.
go back to reference Portale AA, Halloran BP, Morris RC Jr (1989) Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 83:1494–1499PubMedCrossRef Portale AA, Halloran BP, Morris RC Jr (1989) Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 83:1494–1499PubMedCrossRef
32.
go back to reference Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zanchetti A, De Santo NG (2000) Pulse pressure and isolated systolic hypertension association with microalbuminuria. Kidney Int 58:1211–1218PubMedCrossRef Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zanchetti A, De Santo NG (2000) Pulse pressure and isolated systolic hypertension association with microalbuminuria. Kidney Int 58:1211–1218PubMedCrossRef
35.
go back to reference Rossing K, Christensen PK, Hovind P, Parving HH (2005) Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia 48:2241–2247PubMedCrossRef Rossing K, Christensen PK, Hovind P, Parving HH (2005) Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia 48:2241–2247PubMedCrossRef
36.
go back to reference Viswanathan V, Tilak P, Kumpatla S (2012) Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res 136:46–53PubMed Viswanathan V, Tilak P, Kumpatla S (2012) Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res 136:46–53PubMed
37.
go back to reference Cusick M, Chew EY, Hoogwerf B, Agrón E, Wu L, Lindley A, Ferris FL III, Early Treatment Diabetic Retinopathy Study Research Group (2004) Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study report no. 26. Kidney Int 66:1173–1179PubMedCrossRef Cusick M, Chew EY, Hoogwerf B, Agrón E, Wu L, Lindley A, Ferris FL III, Early Treatment Diabetic Retinopathy Study Research Group (2004) Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study report no. 26. Kidney Int 66:1173–1179PubMedCrossRef
38.
go back to reference Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ (1993) Predictors of microalbuminuria in individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 16:1376–1383PubMedCrossRef Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ (1993) Predictors of microalbuminuria in individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 16:1376–1383PubMedCrossRef
39.
40.
go back to reference Shankar A, Klein R, Moss SE, Klein BE, Wong TY (2004) The relationship between albuminuria and hypercholesterolemia. J Nephrol 17:658–665PubMed Shankar A, Klein R, Moss SE, Klein BE, Wong TY (2004) The relationship between albuminuria and hypercholesterolemia. J Nephrol 17:658–665PubMed
41.
go back to reference Nakhjavani M, Esteghamati A, Khalilzadeh O, Asgarani F, Mansournia N, Abbasi M (2010) Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case–control study. Int Urol Nephrol 42:487–492. doi:10.1007/s11255-009-9643-9 PubMedCrossRef Nakhjavani M, Esteghamati A, Khalilzadeh O, Asgarani F, Mansournia N, Abbasi M (2010) Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case–control study. Int Urol Nephrol 42:487–492. doi:10.​1007/​s11255-009-9643-9 PubMedCrossRef
42.
go back to reference Prakash J, Sen D, Usha, Kumar NS (2001) Non-diabetic renal disease in patients with type 2 diabetes mellitus. J Assoc Physicians India 49:415–420PubMed Prakash J, Sen D, Usha, Kumar NS (2001) Non-diabetic renal disease in patients with type 2 diabetes mellitus. J Assoc Physicians India 49:415–420PubMed
Metadata
Title
Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus
Authors
Yit-Sheung Yap
Hung-Yi Chuang
Wen-Che Chi
Cheng-Hao Lin
Yi-Wen Wu
Pai-Chun Chang
Yi-Chun Liu
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0378-2

Other articles of this Issue 5/2013

International Urology and Nephrology 5/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.